Sequent Scientific Limited - Company Profile

It is a chemicals public limited company based in Shaikpet, Telangana, India, established in 1985.
1985 Shaikpet, Telangana, India Active
Last Updated:
About Sequent Scientific Limited

Sequent Scientific Limited, a active public limited company, was established on 28 June 1985 in Shaikpet, Telangana, India. Engaging in pharmaceuticals within the manufacturing sector, it holds CIN: L99999TS1985PLC196357. Registered under ROC Roc Hyderabad. it is listed on BSE: 512529 and NSE: EQUENT. It has an authorized capital of ₹886.15 Cr and a paid-up capital of ₹50.82 Cr.

Formerly known as Visistha Trades & Finance Limited, P.I. Drugs & Pharmaceuticals Limited. It upholds a compliant status. In 2023, it reported revenue of ₹250.93 Cr and a net worth of ₹1,058.36 Cr. Employing 399 professional, Its leadership includes Gregory John Andrews (Director), Fabian Martin Kausche (Director), Revati Parag Kasture (Director). Past directors included Gautam Kumar Das, Joe Thomas Mangalam, Ramanujam Kannan. It holds ₹792.71 Cr open charges and ₹1,663.84 Cr settled loans. Its latest AGM occurred on 08 August 2025, with the balance sheet filed on 31 March 2025. It is based at 3Rd Floor, Srivalli S Corporate, Plot No. 290,, Syn 33 34P To 39, Guttala Begumpet, Shaikpet, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L99999TS1985PLC196357

  • Registration Number

    196357

  • Incorporation Date

    28 June 1985

  • Authorized Capital

    ₹886.15 Cr

  • Paid-Up Capital

    ₹50.82 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Listed (BSE: 512529, NSE: EQUENT)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 886.15 Cr
  • Paid Up Capital ₹ 50.82 Cr
  • Company Age 40 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 792.71 Cr
  • Satisfied Charges ₹ 1,663.84 Cr
  • Revenue Growth **** 1.48%
  • Profit Growth **** -141.08%
  • Ebitda **** -3414.67%
  • Net Worth 1.66%
  • Total Assets -0.13%
Company report

Sequent Scientific Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sequent Scientific Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sequent Scientific Limited?
Current Directors
Name Designation Appointment Date Status
Gregory John Andrews Director 06 Nov 2020 Current
Fabian Martin Kausche Director 14 Dec 2020 Current
Revati Parag Kasture Director 17 Dec 2024 Current
Milind Shripad Sarwate Director 25 Aug 2020 Current
Kamal Kishore Sharma Director 25 Aug 2020 Current
Anuj Vishnukumar Poddar Director 05 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 08 Jan 2017 Past
Pramod Abcsdd Director 18 Jan 2012 Past
Pramod Abcsdd Director 11 Feb 2016 Past
Pramod Abcsdd Additional Director 23 Sep 2016 Past
Pramod Abcsdd Additional Director 23 Sep 2016 Past
Pramod Abcsdd Additional Director 17 Jan 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sequent Scientific.

Sequent Scientific Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.48% increase. The company also saw a substantial fall in profitability, with a 141.08% decrease in profit. The company's net worth moved up by a moderate rise of 1.66%.

Sequent Scientific revenue growth over time
Sequent Scientific profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
1.48%
*******
*******
*******
*******
Revenue from Operations
*******
1.39%
*******
*******
*******
*******
Total Assets
*******
-0.13%
*******
*******
*******
*******
Profit or Loss
*******
-141.08%
*******
*******
*******
*******
Net Worth
*******
1.66%
*******
*******
*******
*******
EBITDA
*******
-3414.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sequent Scientific?

In 2016, Sequent Scientific had a promoter holding of 56.25% and a public holding of 43.75%. The company had 7 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,927,084,880.00

Satisfied Charges

₹16,638,400,000.00

Charges Breakdown by Lending Institutions
  • Others : 700.41 Cr
  • Hdfc Bank Limited : 92.30 Cr
Latest Charge Details
Date Lender Amount Status
27 Oct 2025 Hdfc Bank Limited ₹3.89 M Open
04 Oct 2025 Hdfc Bank Limited ₹3.89 M Open
25 Sep 2025 Hdfc Bank Limited ₹1.75 M Open
24 Sep 2025 Hdfc Bank Limited ₹1.65 M Open
05 Mar 2025 Hdfc Bank Limited ₹2.46 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Sequent Scientific?

Sequent Scientific has a workforce of 399 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sequent Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Scientific's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sequent Scientific
Recent Activity within the Organization
  • Director Appointment

    Progress on Hari Babu Bodepudi was appointed as a CEO was appointed as a CEO on 16 Dec 2025 & has been associated with this company since 2 months 13 days . was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101188521 was registered on 27 Oct 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101169395 was registered on 04 Oct 2025. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101177637 was registered on 25 Sep 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 101177005 was registered on 24 Sep 2025. was completed.

  • Director Appointment

    Anuj Vishnukumar Poddar was appointed as a Director was appointed as a Director on 05 Sep 2025 & has been associated with this company since 5 months 23 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Sequent Scientific Limited?

The CIN of Sequent Scientific Limited is L99999TS1985PLC196357.

Where is Sequent Scientific Limited headquartered?

Sequent Scientific Limited is headquartered at 3Rd Floor, Srivalli S Corporate, Plot No. 290,, Syn 33 34P To 39, Guttala Begumpet, Shaikpet, Telangana, 500033.

When was Sequent Scientific Limited incorporated?

Sequent Scientific Limited was incorporated on 28 June 1985.

Who are the current directors of Sequent Scientific Limited?
What is the primary industry of Sequent Scientific Limited?

The primary industry of Sequent Scientific Limited is Manufacturing.

Is Sequent Scientific Limited a listed company?

Sequent Scientific Limited is listed. It is listed on BSE: 512529 and NSE: EQUENT.

What is the capital structure of Sequent Scientific Limited?

The authorized capital of Sequent Scientific Limited is ₹886.15 Cr, and the paid-up capital is ₹50.82 Cr.

What is the compliance status of Sequent Scientific Limited?

The compliance status of Sequent Scientific Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available